These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36169712)

  • 41. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
    Greze E; Benard M; Hamon I; Casper C; Haddad FE; Boutroy MJ; Hascoët JM
    Paediatr Drugs; 2016 Dec; 18(6):443-449. PubMed ID: 27612991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of caffeine on the ventilatory response to hypercarbia in preterm infants.
    Rossor T; Bhat R; Ali K; Peacock J; Rafferty GF; Greenough A
    Pediatr Res; 2018 Jun; 83(6):1152-1157. PubMed ID: 29790869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Caffeine: Some of the Evidence behind Its Use and Abuse in the Preterm Infant.
    Chavez L; Bancalari E
    Neonatology; 2022; 119(4):428-432. PubMed ID: 35691280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caffeine citrate for apnea of prematurity-One dose does not fit all a prospective study.
    Rosen C; Taran C; Hanna M; Gueta I; Loebstein R; Strauss T; Yarden-Bilavsky H
    J Perinatol; 2021 Sep; 41(9):2292-2297. PubMed ID: 34290376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity.
    Chereches-Panta P; Nanulescu MV; Culea M; Palibroda N
    J Perinatol; 2007 Nov; 27(11):709-12. PubMed ID: 17717520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
    Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
    Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists.
    Abu Jawdeh EG; O'Riordan M; Limrungsikul A; Bandyopadhyay A; Argus BM; Nakad PE; Supapannachart S; Yunis KA; Davis PG; Martin RJ
    J Neonatal Perinatal Med; 2013; 6(3):251-6. PubMed ID: 24246598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacologic management of apnea of prematurity.
    Calhoun LK
    J Perinat Neonatal Nurs; 1996 Mar; 9(4):56-62. PubMed ID: 8699367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caffeine for apnea of prematurity.
    Coulter DM
    N Engl J Med; 2006 Aug; 355(9):958-9; author reply 959-60. PubMed ID: 16943412
    [No Abstract]   [Full Text] [Related]  

  • 50. Caffeine Administration to Prevent Apnea in Very Premature Infants.
    Armanian AM; Iranpour R; Faghihian E; Salehimehr N
    Pediatr Neonatol; 2016 Oct; 57(5):408-412. PubMed ID: 26976495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit.
    Ye C; Miao C; Yu L; Dong Z; Zhang J; Mao Y; Lu X; Lyu Q
    Pediatr Neonatol; 2019 Feb; 60(1):43-49. PubMed ID: 29673564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caffeine citrate therapy for apnea of prematurity.
    Johnson PJ
    Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M; Lipowsky G; Stöckl H; Stiegler H
    Monatsschr Kinderheilkd; 1981 Dec; 129(12):697-702. PubMed ID: 7329425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants.
    Murat I; Moriette G; Blin MC; Couchard M; Flouvat B; De Gamarra E; Relier JP; Dreyfus-Brisac C
    J Pediatr; 1981 Dec; 99(6):984-9. PubMed ID: 7310594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study.
    Yun WZ; Kassab YW; Yao LM; Khairuddin N; Ming LC; Hadi MA
    Int J Clin Pharm; 2022 Oct; 44(5):1140-1148. PubMed ID: 35915341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duration of Caffeine for Apnea of Prematurity-A Randomized Controlled Trial.
    Prakash R; Pournami F; Prabhakar J; Nandakumar A; Nair PMC; Jain N
    Indian J Pediatr; 2021 Dec; 88(12):1174-1179. PubMed ID: 33625665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apnea of prematurity: theophylline v. caffeine.
    Harrison H
    Alaska Med; 1992; 34(4):173-6. PubMed ID: 1288312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants.
    Romagnoli C; De Carolis MP; Muzii U; Zecca E; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A
    Ther Drug Monit; 1992 Feb; 14(1):14-9. PubMed ID: 1546385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
    He T; Liao ZC; Ding Y; Wang MJ; Li W; Gan JM; Yue SJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):684-689. PubMed ID: 32669161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.
    Aranda JV; Gorman W; Bergsteinsson H; Gunn T
    J Pediatr; 1977 Mar; 90(3):467-72. PubMed ID: 14241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.